NCT06539260View on ClinicalTrials.gov

Clinical Relationship Between Vitamin D-mediated Th17 and Treg Cells and Parkinson's Disease

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

July 1, 2024

Study Completion Date

July 1, 2024

Conditions
NeurologyImmunology
Interventions
DRUG

Vitamin D

Take 400 units of vitamin D3, twice daily, for a duration of 3 months.

DRUG

Placebo

Take a placebo that is identical in appearance and weight to 400 units of vitamin D3, twice daily, for a duration of 3 months.

Trial Locations (1)

234000

Suzhou Hospital of Anhui Medical University, Suzhou

All Listed Sponsors
lead

Suzhou Municipal Hospital of Anhui Province

OTHER